Prevalence of Human Parvovirus B19 Infection among Apparently Healthy Pregnant Women Attending Selected Antenatal Care Units, Khartoum State, Sudan
Open Access
- 30 December 2025
- journal article
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 4 (18) , 2933
Abstract
Fetuses and pregnant women are at risk of serious complications as a result of human parvovirus B19 infection, including non-immune hydrops, intrauterine fetal death, and fetal death. This study was conducted to determine the seroprevalence of Parvovirus B19 immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies among apparently healthy pregnant women and to identify the risk factors associated with B19 infection. Blood samples were collected from consenting pregnant women who were attending antenatal care units in Khartoum state, Sudan, from the period between September 2018 and August 2019. The enzyme-linked immunosorbent assay (ELISA) technique was used to detect Parvovirus B19 IgG and IgM antibodies in the sera of pregnant women. A structured questionnaire was administered to collect data on sociodemographic characteristics and potential risk factors. A total of 93 pregnant women were enrolled and screened for Parvovirus B19 IgM and IgG antibodies; their ages ranged from 15 to 45 years old. Overall, 8 (8.6%) were positive for Parvovirus B19 IgM antibodies, and 19 (20.4%) had IgG antibodies. Those aged 25-35 years had the highest prevalence of IgM antibodies 7 (7.5%) and IgG antibodies (13 (14%) there were a significant relations between B19 IgM, IgG seropositivity and age (p-value = 0.028,0.034) respectively, but no significant association between Parvovirus B19 seropositivity and gravidity, history of blood transfusion, or history of miscarriages (p>0.05). The prevalence of the B19 virus was low among apparently healthy pregnant women in Khartoum State, Sudan.Keywords
This publication has 16 references indexed in Scilit:
- Parvovirus B19 infection in children: a comprehensive review of clinical manifestations and managementItalian Journal of Pediatrics, 2024
- Parvovirus B19 in Pregnancy—Do We Screen for Fifth Disease or Not?Life, 2024
- Parvovirus B19 Infection and Pregnancy: Review of the Current KnowledgeJournal of Personalized Medicine, 2024
- Parvovirus B19: Insights and implication for pathogenesis, prevention and therapyAspects of Molecular Medicine, 2023
- Systematic review and synthesis of stillbirths and late miscarriages following SARS-CoV-2 infectionsAmerican Journal of Obstetrics and Gynecology, 2023
- Intrauterine fetal death during COVID‐19 pregnancy: Typical fetal heart rate changes, coagulopathy, and placentitisJournal of Obstetrics and Gynaecology Research, 2022
- Molecular detection of human parvovirus B19 in umbilical cord blood: Case study of Tehran, IranGene Reports, 2021
- The seroprevalence of parvovirus B19 infection in pregnant women in SudanEpidemiology and Infection, 2014
- Parvovirus B19 antibodies and correlates of infection in pregnant women attending an antenatal clinic in central NigeriaMemórias do Instituto Oswaldo Cruz, 2011
- Aetiology, Diagnosis and Treatment of Hydrops FoetalisCurrent Pediatric Reviews, 2005